Newsroom

Sorted by: Latest

-

Ionis announces positive interim data from partner Roche’s Phase 3 IMAgINATION study in IgA nephropathy (IgAN)

CARLSBAD, Calif.--(BUSINESS WIRE)--Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) and partner Roche today announced positive prespecified interim results from the ongoing Phase 3 IMAgINATION study evaluating investigational sefaxersen in adults with primary IgA nephropathy (IgAN). The study met its primary endpoint with sefaxersen achieving statistically significant and clinically meaningful improvements in proteinuria reduction, compared to placebo at 37 weeks, as measured by 24-hour urine protein...
-

Positive Interim Data Shows Genentech’s Sefaxersen Significantly Reduces Proteinuria in People With IgA Nephropathy (IgAN)

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROP; OTCQX: RHHBY), announced today positive prespecified interim results from the ongoing Phase III IMAgINATION study evaluating investigational sefaxersen in adults with primary IgA nephropathy (IgAN). The study met its primary endpoint with sefaxersen achieving statistically significant and clinically meaningful improvements in proteinuria reduction, compared to placebo at 37 weeks, as measured by...
-

EADV 2026: Galderma to Unveil New Data Advancing Understanding of Skin Diseases, Skin Longevity, and Real-world Patient Experiences

ZUG, Switzerland--(BUSINESS WIRE)--Galderma (SIX: GALD), the pure-play dermatology category leader, will present 19 abstracts and deliver a broad scientific education program at the 2026 European Academy of Dermatology and Venereology (EADV) Congress. Through these activities, Galderma will showcase how it continues to advance its pipeline and the science of dermatology, deepening understanding of biological and quality-of-life factors, while driving innovation in targeted treatments, skin long...
-

Oticon Medical Launches SmartCharger for the Ponto 5 Family

GOTHENBURG, Sweden--(BUSINESS WIRE)--Oticon Medical launches SmartCharger for the Ponto 5 family, introducing its first rechargeable solution for percutaneous sound processors...
-

XENE Investors Have Opportunity to Join Xenon Pharmaceuticals Inc. Fraud Investigation with SBS Law

LOS ANGELES--(BUSINESS WIRE)--XENE Investors Have Opportunity to Join Xenon Pharmaceuticals Inc. Fraud Investigation with SBS Law...
-

PLCE Investors Have Opportunity to Join The Children's Place Inc. Fraud Investigation with SBS Law

LOS ANGELES--(BUSINESS WIRE)--PLCE Investors Have Opportunity to Join The Children's Place Inc. Fraud Investigation with SBS Law...
-

BETR Investors Have Opportunity to Lead Better Home & Finance Holding Company Securities Fraud Lawsuit with SBS Law 

LOS ANGELES--(BUSINESS WIRE)--BETR Investors Have Opportunity to Lead Better Home & Finance Holding Company Securities Fraud Lawsuit with SBS Law...
-

Textron Aviation celebra la entrega del Cessna Citation Latitude número 500

WICHITA, Kansas--(BUSINESS WIRE)--Textron Aviation Inc., una empresa de Textron Inc. (NYSE:TXT), anunció hoy la entrega del avión ejecutivo Cessna Citation Latitude número 500 desde su planta de fabricación en Wichita, Kansas. Este hito de producción reafirma el éxito sostenido del avión ejecutivo de tamaño mediano más vendido del mundo y reconoce el trabajo de los empleados cuya dedicación y destreza han contribuido a convertir al Citation Latitude en una opción de confianza para operadores de...
-

Leifer Properties Enters Houston Market Through Fourth Joint Acquisition with Endeavor Capital

HOUSTON--(BUSINESS WIRE)--Leifer Properties and Endeavor Capital have acquired 10541 Cypress Creek Parkway, a fully occupied, 36,000-square-foot small-bay industrial complex in Northwest Houston, marking Leifer and Endeavor’s entry into the Houston market and the partners' fourth deal together. Situated on 3.2 acres along the FM 1960 corridor, the property comprises three small-bay buildings divided into nine suites ranging from roughly 3,000 to 7,500 square feet, fully leased to tenants in aut...
-

Samenvatting: Textron Aviation viert uitrol van 500e Cessna Citation Latitude

WICHITA, Kan.--(BUSINESS WIRE)--Textron Aviation Inc., een dochteronderneming van Textron Inc. (NYSE:TXT), heeft vandaag de uitrol aangekondigd van de 500e Cessna Citation Latitude-zakenjet vanuit de productiefaciliteit van het bedrijf in Wichita, Kansas. Deze productiemijlpaal onderstreept het aanhoudende succes van 's werelds bestverkochte zakelijke jet in het middensegment en vormt een erkenning voor de medewerkers; hun vakmanschap en toewijding hebben ervoor gezorgd dat de Citation Latitude...